CXCL10 levels in the remission PMR group were not significantly different from those in the RA group (Z =  − 0.893, P = 0.372), nor from those in the healthy control group (Z =  − 0.660, P = 0.509), as shown in Fig. 2. This evidence concerns the gene CXCL10 and rheumatoid arthritis.